| Variable | Frequency | Percentage |
| Age category: |
|
|
| <60 years | 26 | 39.4% |
| ≥60 years | 40 | 60.6% |
| Surgery type: |
|
|
| TAH & BSO | 61 | 92.4% |
| Subtotal hysterectomy | 5 | 7.6% |
| Tumor size: |
|
|
| ≤4 cm | 37 | 56.1% |
| >4 cm | 29 | 43.9% |
| Lower uterine segment: |
|
|
| Involved | 26 | 39.4% |
| Not involved | 40 | 60.6% |
| Lymphadenectomy: |
|
|
| Done | 49 | 74.2% |
| Not done | 17 | 25.8% |
| Lymphovascular space invasion: |
|
|
| Present | 23 | 34.8% |
| Absent | 28 | 42.4% |
| Not assessed | 15 | 22.7% |
| Post-operative treatment type: |
|
|
| No adjuvant radiation therapy | 20 | 30.3% |
| Adjuvant radiation therapy | 46 | 69.7% |
| Type of adjuvant radiation therapy: |
|
|
| External pelvic radiotherapy | 16 | 24.2% |
| Vaginal brachytherapy | 14 | 21.2% |
| Both | 16 | 24.2% |
| Relapse: |
|
|
| Yes | 14 | 21.2% |
| No | 52 | 78.8% |
| Site of relapse: |
|
|
| Pelvic | 10 | 15.1% |
| Vaginal | 4 | 6.1% |